Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
AstraZeneca
Age
Any age
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Provision of informed consent prior to any study specific procedures.
Participated in the Iressa EAP in China.
Diagnosed as NSCLC.
Patients who started EAP at least 3 years before this study initiated and have not yet terminated from the EAP (active long-term survivors).
Patients who consent to provide blood sample and available archival tumour tissue sample for EGFR gene testing (provision of tumour tissue sample is optional).
You may not be if
Patients who disagree to participate this study.
Patients in whose medical objection was recorded to use the existing data from medical practice for scientific research.
Clareo Health | A Study on the Long Term Survivals in an Expand Access Program (EAP) of Iressa
